{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"GT60","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"This study was terminated before completion of the dose escalation phase (Part A), due to strategic business decision made by the company."},"pointOfContact":{"email":"ClinicalTrials.gov@lilly.com","organization":"Eli Lilly and Company","phone":"800-545-5979","title":"Chief Medical Officer"}}